Showing results (211-220 of 463) with videos related to
Sort By:
Pageof 47
Experimental Neurology|December 31, 2002
Altered proteasomal function in sporadic Parkinson's diseaseKevin St P McNaught, Roger Belizaire, Ole Isacson, et al.Movement Disorders : Official Journal of the Movement Disorder Society|November 6, 2012
Levodopa infusion does not decrease the onset of abnormal involuntary movements in parkinsonian ratsMaria Papathanou, Rika van der Laan, Peter Jenner, et al.Journal of Molecular Neuroscience : MN|October 24, 2013
Proteomic analysis of striatum from MPTP-treated marmosets (Callithrix jacchus) with L-DOPA-induced dyskinesia of differing severityMichael J Hurley, Michael J Jackson, Lance A Smith, et al.Frontiers in Human Neuroscience|May 27, 2014
Effects of robot assisted gait training in progressive supranuclear palsy (PSP): a preliminary reportPatrizio Sale, Fabrizio Stocchi, Daniele Galafate, et al.Brain Research|July 9, 2011
The effect of nNOS inhibitors on toxin-induced cell death in dopaminergic cell lines depends on the extent of enzyme expressionMonika J Brzozowski, Susana Lopez Alcantara, Mahmoud M Iravani, et al.Behavioural Pharmacology|April 28, 2011
A major metabolite of bupropion reverses motor deficits in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated common marmosetsMatthew J Hansard, Michael J Jackson, Lance A Smith, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|October 10, 2003
3,4-methylenedioxymethamphetamine (ecstasy) inhibits dyskinesia expression and normalizes motor activity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primatesMahmoud M Iravani, Michael J Jackson, Mikko Kuoppamäki, et al.Movement Disorders : Official Journal of the Movement Disorder Society|May 2, 2003
Effect of pulsatile administration of levodopa on dyskinesia induction in drug-naïve MPTP-treated common marmosets: effect of dose, frequency of administration, and brain exposureLance A Smith, Michael J Jackson, Matthew J Hansard, et al.Neuroscience Letters|January 28, 2012
Lipopolysaccharide-induced nigral inflammation leads to increased IL-1β tissue content and expression of astrocytic glial cell line-derived neurotrophic factorMahmoud M Iravani, Mona Sadeghian, Clement C M Leung, et al.Therapeutic Advances in Neurological Disorders|November 13, 2023
Feasibility of home dose optimization of apomorphine sublingual film in Parkinson's disease patients with OFF episodes: results from the dose-optimization phase of an open-label, randomized crossover studyJan Kassubek, Fabrizio Stocchi, Ernest Balaguer Martinez, et al.Pageof 47